These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 36824451)

  • 1. The intersection of obesity and (long) COVID-19: Hypoxia, thrombotic inflammation, and vascular endothelial injury.
    Xiang M; Wu X; Jing H; Novakovic VA; Shi J
    Front Cardiovasc Med; 2023; 10():1062491. PubMed ID: 36824451
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long COVID: The Nature of Thrombotic Sequelae Determines the Necessity of Early Anticoagulation.
    Wang C; Yu C; Jing H; Wu X; Novakovic VA; Xie R; Shi J
    Front Cell Infect Microbiol; 2022; 12():861703. PubMed ID: 35449732
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.
    Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S
    Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Persistent Lung Injury and Prothrombotic State in Long COVID.
    Xiang M; Jing H; Wang C; Novakovic VA; Shi J
    Front Immunol; 2022; 13():862522. PubMed ID: 35464473
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanisms of SARS-CoV-2-induced lung vascular disease: potential role of complement.
    Stenmark KR; Frid MG; Gerasimovskaya E; Zhang H; McCarthy MK; Thurman JM; Morrison TE
    Pulm Circ; 2021; 11(2):20458940211015799. PubMed ID: 34046161
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The coagulopathy, endotheliopathy, and vasculitis of COVID-19.
    Iba T; Connors JM; Levy JH
    Inflamm Res; 2020 Dec; 69(12):1181-1189. PubMed ID: 32918567
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IL-1 induces throboxane-A2 (TxA2) in COVID-19 causing inflammation and micro-thrombi: inhibitory effect of the IL-1 receptor antagonist (IL-1Ra).
    Conti P; Caraffa A; Gallenga CE; Ross R; Kritas SK; Frydas I; Younes A; Di Emidio P; Ronconi G; Toniato E
    J Biol Regul Homeost Agents; 2020 Sep-Oct,; 34(5):1623-1627. PubMed ID: 32744052
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The cross-talk of lung and heart complications in COVID-19: Endothelial cells dysfunction, thrombosis, and treatment.
    Liu L; Jing H; Wu X; Xiang M; Novakovic VA; Wang S; Shi J
    Front Cardiovasc Med; 2022; 9():957006. PubMed ID: 35990983
    [TBL] [Abstract][Full Text] [Related]  

  • 10. COVID-19 coagulopathy - what should we treat?
    Chowdary P
    Exp Physiol; 2022 Jul; 107(7):749-758. PubMed ID: 35733235
    [TBL] [Abstract][Full Text] [Related]  

  • 11. COVID-19 is a systemic vascular hemopathy: insight for mechanistic and clinical aspects.
    Smadja DM; Mentzer SJ; Fontenay M; Laffan MA; Ackermann M; Helms J; Jonigk D; Chocron R; Pier GB; Gendron N; Pons S; Diehl JL; Margadant C; Guerin C; Huijbers EJM; Philippe A; Chapuis N; Nowak-Sliwinska P; Karagiannidis C; Sanchez O; Kümpers P; Skurnik D; Randi AM; Griffioen AW
    Angiogenesis; 2021 Nov; 24(4):755-788. PubMed ID: 34184164
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathogenesis-directed therapy of 2019 novel coronavirus disease.
    Stratton CW; Tang YW; Lu H
    J Med Virol; 2021 Mar; 93(3):1320-1342. PubMed ID: 33073355
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SARS CoV-2 related microvascular damage and symptoms during and after COVID-19: Consequences of capillary transit-time changes, tissue hypoxia and inflammation.
    Østergaard L
    Physiol Rep; 2021 Feb; 9(3):e14726. PubMed ID: 33523608
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endothelium dysfunction and thrombosis in COVID-19 with type 2 diabetes.
    Li M; Wu X; Shi J; Niu Y
    Endocrine; 2023 Oct; 82(1):15-27. PubMed ID: 37392341
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mild COVID-19 and Impaired Blood Cell-Endothelial Crosstalk: Considering Long-Term Use of Antithrombotics?
    Melkumyants A; Buryachkovskaya L; Lomakin N; Antonova O; Serebruany V
    Thromb Haemost; 2022 Jan; 122(1):123-130. PubMed ID: 34482535
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intensive care for seriously ill patients affected by novel coronavirus sars - CoV - 2: Experience of the Crema Hospital, Italy.
    Zuccon W; Comassi P; Adriani L; Bergamaschini G; Bertin E; Borromeo R; Corti S; De Petri F; Dolci F; Galmozzi A; Gigliotti A; Gualdoni L; Guerra C; Khosthiova A; Leati G; Lupi G; Moscato P; Perotti V; Piantelli M; Ruini A; Sportelli S; Susca M; Troiano C; Benelli G; Buscarini E; Canetta C; Merli G; Scartabellati A; Melilli B S C G; Sfogliarini R; Pellegatta G; Viganò G
    Am J Emerg Med; 2021 Jul; 45():156-161. PubMed ID: 33046317
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impaired coagulation, liver dysfunction and COVID-19: Discovering an intriguing relationship.
    D'Ardes D; Boccatonda A; Cocco G; Fabiani S; Rossi I; Bucci M; Guagnano MT; Schiavone C; Cipollone F
    World J Gastroenterol; 2022 Mar; 28(11):1102-1112. PubMed ID: 35431501
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of platelets on pulmonary microcirculation throughout COVID-19 and its persistent activating factors.
    Xiang M; Wu X; Jing H; Liu L; Wang C; Wang Y; Novakovic VA; Shi J
    Front Immunol; 2022; 13():955654. PubMed ID: 36248790
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Markers of endothelial cell activation are associated with the severity of pulmonary disease in COVID-19.
    Osburn WO; Smith K; Yanek L; Amat-Alcaron N; Thiemann DR; Cox AL; Leucker TM; Lowenstein CJ
    PLoS One; 2022; 17(5):e0268296. PubMed ID: 35588115
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.